ANI Pharmaceuticals (BSFA) Q1 2025 Earnings Report
CH:BSFA Q1 2025 EPS Results
- Actual EPS
- CHF 1.39
- Consensus EPS
- CHF 1.13
- Beat/Miss
- Beat by +CHF 0.26
- One Year Ago EPS
- CHF 0.99
CH:BSFA Q1 2025 Revenue Results
- Actual Revenue
- CHF 161.59M
- Expected Revenue
- CHF 148.07M
- Beat/Miss
- Beat by +CHF 13.51M
- YoY Revenue Growth
- +43.43%
Earnings Announcement Details
- Quarter
- Q1 2025
- Date
- 05/09/2025
- Time
- Before Open
- Conference Call
- Friday, May 9, 2025
CH:BSFA Upcoming Earnings
ANI Pharmaceuticals's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q1 2025 Earnings Call Audio
CH:BSFA Q1 2025 Earnings Call
0:00 / 0:00
Q1 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:BSFA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 1.79- | 1.67 | ― | ― |
| Aug 07, 2026 | 2026 (Q2) | 1.671.81 | 1.48 | 22.78% (+0.34) | |
| May 08, 2026 | 2026 (Q1) | 1.061.68 | 1.39 | 20.59% (+0.29) | |
| Mar 03, 2026 | 2025 (Q4) | 1.631.91 | 1.34 | 42.94% (+0.57) | |
| Nov 10, 2025 | 2025 (Q3) | 1.451.67 | 1.1 | 52.24% (+0.57) | |
| Aug 08, 2025 | 2025 (Q2) | 1.151.48 | 0.84 | 76.47% (+0.64) | |
| May 09, 2025 | 2025 (Q1) | 1.131.39 | 0.99 | 40.50% (+0.40) | |
| Feb 28, 2025 | 2024 (Q4) | 1.181.34 | 0.82 | 63.00% (+0.52) | |
| Nov 08, 2024 | 2024 (Q3) | 0.891.10 | 1.04 | 5.51% (+0.06) | |
| Aug 06, 2024 | 2024 (Q2) | 0.780.84 | 1.05 | -20.31% (-0.21) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
